M
Myosotis
A communication platform for the care sector
About Myosotis
Myosotis, operating under the brand MYO, is a German health-tech company that has developed a communication and organization platform specifically for the nursing and care sector. Founded in 2018 by Jasper Böcker and Felix W T. Wenzel, the company aims to address the communication inefficiencies and documentation burdens prevalent in inpatient and outpatient care facilities. The founders' backgrounds are complementary; Böcker brings experience from the Boston Consulting Group, focusing on digital transformation in the healthcare sector, while Wenzel has a background in building digital platforms. The core of MYO's offering is a GDPR-compliant software-as-a-service (SaaS) application designed to connect caregivers, doctors, relatives, and other stakeholders involved in a patient's care. The platform facilitates secure messaging, digital handover reports, and the sharing of important documents and updates, effectively replacing outdated methods like fax machines, paper notes, and telephone chains. This digital approach aims to save time for nursing staff, allowing them to focus more on direct patient care. The business model is based on subscriptions, with care facilities paying a monthly fee to use the platform. MYO's service streamlines daily routines by centralizing information and making it accessible via smartphones, tablets, or desktop computers. Key features include a digital resident file, a handover book, and a secure chat function for quick coordination. By digitizing these processes, the platform not only enhances efficiency but also improves the quality and documentation of care. The company has seen significant adoption, with several thousand care facilities across Germany utilizing its services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Berlin, Germany
- Employees
- 45
- Open positions
- 7
- Dealroom signal
- 82.8/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Senior Citizens, Tech for Hospitals and Clinics, Tech for Medical Professionals, Physician Support Tools, Health Office Tools, Hard Tech, Health It
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2024 | $8.8M | $35M | BONVENTURE · Capacura · Mountain Partners · Axel Springer Plug and Play Accelerator | ↗ |
| SEED✓Equity / VC | Nov 2020 | $1.1M | $8.3M | BONVENTURE | — |
Growth signals
Latest recorded traffic for Myosotis is 1.5K monthly website visits, up 0% over the last three months. Myosotis's team grew 18.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Think.Health
BONVENTURE
Series A8 investors entered at this stage
Capacura
Mountain Partners
Axel Springer Plug and Play Accelerator
Round Hill Ventures
Twip Impact Ventures
Senioren-Park carpe diem
TVM Capital Life Science
Agaplesion
Other known investors1 additional known investor
Marc penkala
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Myosotis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Myosotis’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







